Analysts’ Recommendations for Expedia
Not many analysts have changed their ratings on Expedia after the CEO change. However, there were many upgrades after the company’s second quarter earnings.
Interested in CTRP? Don't miss the next report.
Receive e-mail alerts for new research on CTRP
Jefferies raised its rating to “buy” from “hold.” Jefferies increased its target price from $140 to $180. Barclays raised its target price from $140 to $165. UBS raised its target price from $155 to $178, while Wells Fargo raised its target price from $160 to $180. Benchmark raised its target price from $165 to $182. Credit Suisse raised its price target from $162 to $175 with an “outperform” rating. Moffett Nathanson cut its target price from $180 to $175 and maintained its “buy” rating. RBC raised its target price from $160 to $175. J.P. Morgan raised its target price from $149 to $160.
According to Bloomberg’s consensus, out of the 31 analysts tracking Expedia (EXPE), 22.6% (seven analysts) have a “strong buy” recommendation on the stock, 58.1% (18 analysts) have a “buy” recommendation, and 19.4% (six analysts) have a “hold” recommendation. None of the analysts have a “sell” rating on the stock.
Expedia’s consensus 12-month target price of $176 is higher than the previous consensus of $154.9. The current target price indicates an 18.7% return potential based on the closing price of $148.3 on September 1. The stock has the lowest target price of $154 and the highest target price of $190.
Priceline (PCLN) has a 12-month target price of $2,100.7, which indicates a return potential of 14.1%. Ctrip.com (CTRP) has a 12-month target price of $60.2, which indicates a return potential of 19.8%. TripAdvisor (TRIP) has a 12-month target price of $39.8, which indicates a return potential of -8.0%.
Investors can gain exposure to Expedia by investing in the PowerShares DWA Consumer Cyclicals Momentum Portfolio (PEZ), which holds 3.2% of its portfolio in Expedia.